Latest Fox Chase Cancer Center Stories

Blueprint could help guide treatment for patients who have exhausted all other options Fox Chase Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, is now offering patients with advanced cancer a cutting-edge clinical test that will provide them with a unique blueprint of their cancer genes. The new clinical test, known as CancerCode-45TM, evaluates an individual's tumor for genetic alterations in a select group of 45 genes and gives physicians the...

Blueprint could help guide treatment for patients who have exhausted all other options PHILADELPHIA, Jan. 7, 2013 /PRNewswire-USNewswire/ -- Fox Chase Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, is now offering patients with advanced cancer a cutting-edge clinical test that will provide them with a unique blueprint of their cancer genes. The new clinical test, known as CancerCode-45(TM), evaluates an individual's tumor for genetic...

PHILADELPHIA, Dec. 3, 2012 /PRNewswire-USNewswire/ -- On March 1, 2013, leading cancer center administrator and nationally recognized hematology/oncology expert Richard I. Fisher, MD, will assume a set of vital leadership roles at Fox Chase Cancer Center, a member of the Temple University Health System, and Temple University School of Medicine. Currently, Fisher is vice president for strategic and program development at the University of Rochester Medical Center, where he is also...

BEIJING, July 18, 2012 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that its subsidiary Chang'an Hospital has signed a strategic alliance agreement with Fox Chase Cancer Center (FCCC). Under the agreement, Fox Chase Cancer Center will...

Relationship Strengthens Cancer Care and Research Opportunities PHILADELPHIA, July 2, 2012 /PRNewswire-USNewswire/ -- As of July 1, 2012, Fox Chase Cancer Center became a part of Temple University Health System, one of Philadelphia's leading academic health centers, providing access to quality care through its hospitals and multi-specialty satellite facilities while supporting excellence and innovation in education and research. "We are pleased to welcome Fox Chase Cancer Center...

Survival differences between black and white women having breast cancer do not stem from differences in preoperative imaging If racial and ethnic disparities in breast cancer exist, they are not due to differences in the use of imaging to assess the extent of tumors before surgery, according to new findings that will be presented by Fox Chase Cancer Center researchers at the 2012 Annual Meeting of the American Society of Clinical Oncology on Monday, June 4. "It's encouraging that we...

The new model may provide scientists with a better understanding of the disease and help with developing effective interventions Inflammatory breast cancer (IBC) is a very aggressive, often misunderstood type of cancer that is diagnosed more frequently in younger women compared with other types of breast cancer. The five-year survival rate is between 25 and 50 percent—significantly lower than the survival rate for other types of breast cancer. The reason for the poor prognosis is that...

Additional compounds may help first-line drug kill cancer cells, according to new research by scientists at Fox Chase Cancer Center Scientists at Fox Chase Cancer Center are developing a new way to treat pancreatic cancer by boosting the effects of gemcitabine (Gemzar)—the chemotherapy drug that is considered standard therapy for the disease. Although gemcitabine is the first line of defense against pancreatic cancer, many cells find ways to evade the treatment. The new research, which...

Latest findings from Fox Chase Cancer Center reveal that targeting inflammatory pathways may lead to new therapies Scientists at Fox Chase Cancer Center have uncovered more details about how defects in components of the machinery that makes new proteins can lead to blood and other cancers. The findings, which will be presented at the AACR Annual Meeting 2012 on Monday, April 2, may one day lead to new targeted therapies that address those problems. "These findings help explain how...

People are living longer with and after a cancer diagnosis, making survivorship clinics and programs—as well as official guidelines and practices governing the care of survivors—an important emerging component of modern cancer care. Many institutions are looking to gather these resources into an easily understandable plan for their survivors. "Cancer survivors face a lot of unique and very specific challenges," says Crystal S. Denlinger, M.D., a medical oncologist at Fox Chase Cancer...